Cipla Europe NV tied up with Serum Institute of India to distribute vaccines in Europe

Cipla Europe NV, a wholly-owned subsidiary of Cipla Ltd on 20 November 2014 tied up with Serum Institute of India Ltd (SII) to distribute vaccines in Europe.

Created On: Nov 21, 2014 12:09 ISTModified On: Nov 21, 2014 18:32 IST

Cipla Europe NV, a wholly-owned subsidiary of Cipla Ltd on 20 November 2014 tied up with Serum Institute of India Ltd (SII) to distribute vaccines in Europe.

Under the agreement, SII will develop and manufacture paediatric vaccines. On the other hand, Cipla will seek European Medicines Agency approval and market the products in Europe.

Serum Institute of India Ltd (SII)
Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.

Today, Serum Institute of India Ltd is the World's largest producer of Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines.

Vaccines manufactured by the Serum Institute are accredited by the World Health Organization and are being used in around 140 countries across the globe in their national immunization programs.

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

AndroidIOS
Comment ()

Post Comment

7 + 8 =
Post

Comments